17 December 2018 in BJS Open
Background It is not clear whether laparoscopic transcystic exploration (LTCE) laparoscopic choledochotomy (LCD) is superior in the management of choledocholithiasis. In this meta‐analysis, the success of LTCE versus LCD was evaluated. Methods Cochrane Central Register of Controlled Trials, Web of Science, Trip, PubMed, Ovid and Embase databases were searched systematically for relevant literature up to May 2017. Studies that compared the success rate of LTCE and LCD in patients with choledocholithiasis were included. PRISMA guidelines were followed. Multiple independent reviewers contributed on a cloud‐based platform. Random‐effects model was used to calculate odds ratios (ORs) or standardized mean differences (MDs) with 95 per cent confidence intervals. An a priori hypothesis was generated based on clinical experience that LTCE is as successful as LCD. Results Of 3533 screened articles, 25 studies comprising 4224 patients were included. LTCE achieved a lower duct clearance rate than LCD (OR 0.38, 95 per cent c.i. 0·24 to 0·59). It was associated with a shorter duration of surgery (MD −0·86, 95 per cent c.i. −0·97 to −0·77), lower bile leak (OR 0·46, 0·23 to 0·93) and shorter hospital stay (MD −0·78, −1·14 to −0·42) than LCD. There was no statistically significant difference in conversion, stricture formation or reintervention rate. Conclusion LCD has a higher rate of successful duct clearance, but is associated with a longer duration of surgery and hospital stay, and a higher bile leak rate.
9 April 2011 in Annals of Surgical Oncology
22 December 2016 in Liver Transplantation
Management of biliary anastomotic strictures (AS) after liver transplantation remains to be defined. To retrospectively report the endotherapy workload for duct-to-duct AS and its management in Italy. A questionnaire was sent to the Endoscopy Units of Italian Liver Transplantation Centers. Nineteen of the total 21 Units (90%) returned the questionnaire, twelve being high-volume\ud (>250 ERCPs/year) units. During 2013, 248 liver-transplanted (LT) patients underwent AS endotherapy and 560 (7.3%) out of 7,679 ERCPs (median/center 16, range 5‒204) were performed for AS. After unsuccessful ERCP, interventional radiology or surgery was used in 6.0 % and 3.2 % of patients, respectively. The ERCP selection criteria included the trend of liver tests in 84% of the units, associated with AS as documented by non-invasive imaging in 90%. AS was treated by fully covered self expandable metal stent (SEMS) or plastic multistenting (PM) in eight centers, only by PM in ten and by single plastic stenting in one. SEMS was used independently of the overall ERCP workload and removed after three (37%) or six (63%) months. PM was planned at three-month intervals or at stent dysfunction in 94% of the units. The duration of endotherapy was planned up to\ud the radiological resolution of the stricture in most centers. Recurrent AS was treated endoscopically in 79% of centers, by PM in most units and by fully covered SEMS in 5%. In Italy endotherapy is confirmed as the preferred first and second-line management option for AS and progressive plastic multi-stenting is most frequently used
9 November 2021 in British Journal of Surgery
NCNikolaos A Chatzizacharias
Nikolaos A Chatzizacharias
+11
Background: Pancreatoduodenectomy (PD) is frequently the surgical treatment indicated for a number of pathologies. Elderly patients may be denied surgery because of concerns over poor perioperative outcomes. The aim of this study was to evaluate postoperative clinical outcomes and provide evidence on current UK practice in the elderly population after PD. Methods: This was a multicentre retrospective case–control study of octogenarians undergoing PD between January 2008 and December 2017, matched with younger controls from seven specialist centres in the UK. The primary endpoint was 90-day mortality. Secondary endpoints were index admission mortality, postoperative complications, and 30-day readmission rates. Results: In total, 235 octogenarians (median age 81 (range 80–90) years) and 235 controls (age 67 (31–79) years) were included in the study. Eastern Cooperative Oncology Group performance status (median 0 (range 0–3) versus 0 (0–2); P = 0.010) and Charlson Co-morbidity Index score (7 (6–11) versus 5 (2–9); P = 0.001) were higher for octogenarians than controls. Postoperative complication and 30-day readmission rates were comparable. The 90-day mortality rate was higher among octogenarians (9 versus 3 per cent; P = 0.030). Index admission mortality rates were comparable (4 versus 2 per cent; P = 0.160), indicating that the difference in mortality was related to deaths after hospital discharge. Despite the higher 90-day mortality rate in the octogenarian population, multivariable Cox regression analysis did not identify age as an independent predictor of postoperative mortality. Conclusion: Despite careful patient selection and comparable index admission mortality, 90-day and, particularly, out-of-hospital mortality rates were higher in octogenarians.